SCHEMBL25201514

SCHEMBL25201514

COc1ccn2c(CC(=O)C3C(=O)OC(C)(C)OC3=O)cnc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
CSF1R P07333 2/20 0.36
GLA P06280 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 4/20 0.35
PKM P14618 1/20 0.35
GPR139 Q6DWJ6 4/20 0.34
RIPK2 O43353 1/20 0.33
FLT3 P36888 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GAA P10253 1/20 0.32
SLC5A2 P31639 1/20 0.32
KIT P10721 1/20 0.32
METTL3 Q86U44 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25199208 0.77 PRMT5 (0.40) MAPTCSF1RGLAPRMT5WDR77
SCHEMBL25210046 0.77 AKR1C3 (0.42) MAPTCSF1RPRMT5WDR77ALDH1A1
SCHEMBL2265948 0.76 PRMT5 (0.42) MAPTCSF1RPRMT5WDR77ALDH1A1
SCHEMBL23114698 0.70 FLT3 (0.42) MAPTCSF1RGLAPRMT5WDR77
SCHEMBL25196657 0.67 GPR139 (0.39) MAPTCSF1RPRMT5WDR77ALDH1A1
SCHEMBL3951320 0.65 GLA (0.47) GLANPSR1RAB9A
SCHEMBL20926916 0.65 FDPS (0.62) MAPTCSF1RPRMT5WDR77ALDH1A1
SCHEMBL9941702 0.65 KDM4E (0.43) MAPTCSF1RPRMT5WDR77ALDH1A1
SCHEMBL23889155 0.65 NPC1 (0.40) MAPTCSF1RGLANPSR1PRMT5
SCHEMBL25294274 0.65 TAAR1 (0.44) CSF1RPRMT5WDR77KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138948-A1 N-SUBSTITUTED INDOLES AS 5-HYDROXYTRYPTAMINE (5-HT) SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS TERRAN BIOSCIENCES INC (US) 2026-05-21 US disclosed
US-20260078090-A1 N-SUBSTITUTED INDOLES AS 5-HYDROXYTRYPTAMINE (5-HT) SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS TERRAN BIOSCIENCES INC. 2026-03-19 US disclosed
EP-4423060-A2 PSYCHOPLASTOGENIC N-SUBSTITUTED INDOLES Terran Biosciences, Inc. (US) 2024-09-04 EP disclosed
US-20230159456-A1 N-SUBSTITUTED INDOLES TERRAN BIOSCIENCES INC (US) 2023-05-25 US disclosed
US-20230159456-A1 N-SUBSTITUTED INDOLES TERRAN BIOSCIENCES INC (US) 2023-05-25 US disclosed
US-20230159456-A1 N-SUBSTITUTED INDOLES TERRAN BIOSCIENCES INC (US) 2023-05-25 US disclosed
WO-2023077127-A2 N-SUBSTITUTED INDOLES TERRAN BIOSCIENCES, INC. (US) 2023-05-04 WO disclosed
WO-2023077127-A2 N-SUBSTITUTED INDOLES TERRAN BIOSCIENCES, INC. (US) 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078090-A1 N-SUBSTITUTED INDOLES AS 5-HYDROXYTRYPTAMINE (5-HT) SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS HTR1D, TPH1, HTR3D MAPT 1632/4885CSF1R 1653/4885GLA 4729/4885
US-20260138948-A1 N-SUBSTITUTED INDOLES AS 5-HYDROXYTRYPTAMINE (5-HT) SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS HTR1D, HTR2C, TPH1 MAPT 1410/4885CSF1R 1402/4885GLA 4666/4885
US-20230159456-A1 N-SUBSTITUTED INDOLES TPH2, TPH1, AANAT MAPT 96/4885CSF1R 4254/4885GLA 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.